Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-11

Clinical Trial Update: Clinical And Radiographic Evaluation Of Nano-Propolis, Nano-Curcumin and MTA as Direct Pulp Capping Agents in Young Permanant Teeth [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial from Al-Azhar University evaluates nano-propolis, nano-curcumin, and mineral trioxide aggregate as direct pulp-capping agents in you…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MTA (Mineral Trioxide Aggregate) (mineral trioxide aggregate)
  • Nano-Curcumin (curcumin (nano-formulated))
  • Nano-Propolis (propolis nanoparticles)

Snippet

Sponsor: Al-Azhar University | Conditions: Traumatic Pulp Exposure in Children | Phase 1 | Status: COMPLETED